Moses R D, Sundeen J T, Orr K S, Roberts R R, Gress R E
Experimental Immunology Branch, National Cancer Institute, National Institute of Health, Bethesda, Maryland 20892.
Transplantation. 1989 Nov;48(5):769-73. doi: 10.1097/00007890-198911000-00009.
We have studied organ allograft survival in rhesus monkeys conditioned with myeloablative total-body irradiation and T cell-depleted autologous bone marrow transplantation then given a heterotopic MHC-mismatched cardiac allograft in the immediate postmyeloablative period. This model has enabled us to investigate the role of T cells in vascularized organ allograft rejection. We previously reported (1) that recipients of marrow depleted of T cells below a critical threshold (0.16% residual marrow T cells, or 0.14 x 10(5) infused T cells/kg) experienced a period of freedom from acute rejection associated with a profound nonspecific immune deficiency (determined by skin grafting). Resolution of the nonspecific immune deficiency was associated with late graft rejection. In the present report, we correlate the results of peripheral immune reconstitution studies and direct immunohistochemical analysis with allograft status in order to study T cell subsets involved in late rejection. We report that, in contrast with CD8+/CD28- T cells, CD16+ NK cells, and CD20+ B cells, late allograft rejection was associated with the return of peripheral CD4+ T cells and CD8+/CD28+ T cells, suggesting a critical role for one or both of these subsets in late allograft rejection in this model.
我们研究了恒河猴在接受清髓性全身照射和去除T细胞的自体骨髓移植预处理后,于清髓后即刻接受异位MHC不匹配心脏同种异体移植的器官同种异体移植存活情况。该模型使我们能够研究T细胞在血管化器官同种异体移植排斥反应中的作用。我们之前报道过,骨髓中T细胞被消耗至临界阈值以下(残余骨髓T细胞0.16%,或每千克输注T细胞0.14×10⁵个)的受体经历了一段无急性排斥反应的时期,这与严重的非特异性免疫缺陷相关(通过皮肤移植确定)。非特异性免疫缺陷的消退与晚期移植物排斥反应相关。在本报告中,我们将外周免疫重建研究结果和直接免疫组织化学分析结果与同种异体移植状态相关联,以研究参与晚期排斥反应的T细胞亚群。我们报告称,与CD8⁺/CD28⁻T细胞、CD16⁺自然杀伤细胞和CD20⁺B细胞不同,晚期同种异体移植排斥反应与外周CD4⁺T细胞和CD8⁺/CD28⁺T细胞的恢复相关,这表明在该模型中这些亚群中的一个或两个在晚期同种异体移植排斥反应中起关键作用。